Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Malignant Glioma
Interventions
DRUG

NPC-07 for oral administration

NPC-07, containing 1.5g of 5-aminolevulinic acid hydrochloride per vial, is dissolved in 50 mL of water and will be administered orally 3 hours (range 2-4 hours) prior to induction of anesthesia at a dose of 20mg/kg body weight.

Trial Locations (3)

350-1298

International Medical Center, Saitama Medical University, Hidaka

104-0045

National Cancer Center Hospital, Chuo-ku

181-8611

Kyorin University Hospital, Mitaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT01167322 - Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas | Biotech Hunter | Biotech Hunter